Travere Therapeutics, Inc. · NASDAQ:TVTX
Cline Christopher R. sold 642 Travere Therapeutics, Inc. shares (Form 4)
Traded Sep 2, 2026 · Filed Sep 3, 2026
On Sep 2, 2026, Cline Christopher R. (CHIEF FINANCIAL OFFICER) sold 642 Travere Therapeutics, Inc. shares at US$66.37 for US$42,610, leaving 118,016 shares. Filed Sep 3, 2026 (Form 4).
- Sold
- 642 shares
- Price
- US$66.37
- Value
- US$42,610
- Holding after
- 118,016 shares
- Trading plan
- No
- Role
- CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Common Stock | Sale | 642 | US$66.37 | 118,016 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Cline Christopher R.
- Travere Therapeutics, Inc. shareholders
- Form 4 · Cline Christopher R. · Sep 17, 2026
- Form 4 · Cline Christopher R. · May 6, 2026
- Form 4 · Cline Christopher R. · Apr 15, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026